Literature DB >> 21136733

THE HUPO Human Plasma Proteome Project.

Gilbert S Omenn1.   

Abstract

The Human Proteomics Organization (HUPO) Human Plasma Proteome Project (PPP) is a prominent example of the inherently collaborative nature of the overall community effort to characterize the proteome of humans in health and disease. The PPP Pilot Phase, called "Exploring the Human Plasma Proteome", engaged 55 laboratories, four technical committees, and vendors and sponsors on an international scale. Among other outcomes, the PPP generated a Core Dataset of 3020 proteins identified with two or more peptides, fully accessible at EBI/PRIDE, ISB/PeptideAtlas, and University of Michigan websites, a rich resource for follow-on analyses. The PPP provided extensive annotation, correlation of number of peptides with protein concentrations measured by immunoassay, an algorithm for choice of a representative protein for multiple proteins matching a given peptide, and independent analyses from the raw spectra. The next phase of the PPP will emphasize standardized procedures for specimen handling, potent new technology platforms for discovery and for targeted proteomics, and robust informatics efforts, including comparative analyses of other biofluids.
Copyright © 2007 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Year:  2007        PMID: 21136733     DOI: 10.1002/prca.200700369

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  9 in total

1.  Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study.

Authors:  Sheng Pan; Ru Chen; Randall E Brand; Sarah Hawley; Yasuko Tamura; Philip R Gafken; Brian P Milless; David R Goodlett; John Rush; Teresa A Brentnall
Journal:  J Proteome Res       Date:  2012-02-08       Impact factor: 4.466

Review 2.  Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.

Authors:  Carol E Parker; Christoph H Borchers
Journal:  Mol Oncol       Date:  2014-03-20       Impact factor: 6.603

Review 3.  Proteomics analysis of bodily fluids in pancreatic cancer.

Authors:  Sheng Pan; Teresa A Brentnall; Ru Chen
Journal:  Proteomics       Date:  2015-04-27       Impact factor: 3.984

Review 4.  Emerging blood-based biomarkers for detection of gastric cancer.

Authors:  Zane Kalniņa; Irēna Meistere; Ilze Kikuste; Ivars Tolmanis; Pawel Zayakin; Aija Linē
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

5.  Identification of small ORF-encoded peptides in mouse serum.

Authors:  Yaqin Deng; Adekunle Toyin Bamigbade; Mirza Ahmed Hammad; Shimeng Xu; Pingsheng Liu
Journal:  Biophys Rep       Date:  2018-03-08

Review 6.  Leveraging Multilayered "Omics" Data for Atopic Dermatitis: A Road Map to Precision Medicine.

Authors:  Debajyoti Ghosh; Jonathan A Bernstein; Gurjit K Khurana Hershey; Marc E Rothenberg; Tesfaye B Mersha
Journal:  Front Immunol       Date:  2018-12-12       Impact factor: 7.561

7.  Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.

Authors:  Sheng Pan; Ru Chen; Yasuko Tamura; David A Crispin; Lisa A Lai; Damon H May; Martin W McIntosh; David R Goodlett; Teresa A Brentnall
Journal:  J Proteome Res       Date:  2014-01-28       Impact factor: 4.466

8.  Integrated analysis of fine-needle-aspiration cystic fluid proteome, cancer cell secretome, and public transcriptome datasets for papillary thyroid cancer biomarker discovery.

Authors:  Chia-Chun Wu; Jen-Der Lin; Jeng-Ting Chen; Chih-Min Chang; Hsiao-Fen Weng; Chuen Hsueh; Hui-Ping Chien; Jau-Song Yu
Journal:  Oncotarget       Date:  2018-01-04

Review 9.  Differential expression of serum/plasma proteins in various infectious diseases: specific or nonspecific signatures.

Authors:  Sandipan Ray; Sandip K Patel; Vipin Kumar; Jagruti Damahe; Sanjeeva Srivastava
Journal:  Proteomics Clin Appl       Date:  2013-12-27       Impact factor: 3.494

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.